Sibrotuzumab, CAS 216669-97-5

Product Description: Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Scott AM, et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003 May;9(5):1639-47.

CAS Number: 216669-97-5

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: FAP

• Artikelnummer: MEXHY-P99269-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99269-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK